Aspergillus and asthma – any link?

References

• Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490–494
   PubMed Web of Science ®Google Scholar
• Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69–75
   PubMed Web of Science ®Google Scholar
• Lugauskas A, Krikstaponis A, Sveistyte L. Airborne fungi in industrial environments–potential agents of respiratory diseases. Ann Agric Environ Med 2004; 11: 19–25
   PubMed Web of Science ®Google Scholar
• Green BJ, Mitakakis TZ, Tovey ER. Allergen detection from 11 fungal species before and after germination. J Allergy Clin Immunol 2003; 111: 285–289
   PubMed Web of Science ®Google Scholar
• Kauffman HF, van der Heide S. Exposure, sensitization, and mechanisms of fungus-induced asthma. Curr Allergy Asthma Rep 2003; 3: 430–437
   PubMed Web of Science ®Google Scholar
• Engelhart S, Hanfland J, Glasmacher A, et al. Impact of portable air filtration units on exposure of hematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions. J Hosp Infect 2003; 54: 300–304
   PubMed Web of Science ®Google Scholar
• Hogaboam CM, Blease K, Mehrad B, et al. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol 2000; 156: 723–732
   PubMed Web of Science ®Google Scholar
• Hogaboam CM, Blease K, Schuh JM. Cytokines and chemokines in allergic bronchopulmonary aspergillosis (ABPA) and experimental Aspergillus-induced allergic airway or asthmatic disease. Front Biosci 2003; 8: e147–156
   PubMed Web of Science ®Google Scholar
• Mehrad B, Moore TA, Standiford TJ. Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J Immunol 2000; 165: 962–968
   PubMedGoogle Scholar
• Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121–127
   PubMed Web of Science ®Google Scholar
• Imai T, Chantry D, Raport CJ, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998; 273: 1764–1768
   PubMed Web of Science ®Google Scholar
• Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol 2003; 111: 520–526
   PubMedGoogle Scholar
• Mariani M, Lang R, Binda E, Panina-Bordignon P, D'Ambrosio D. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization, and internalization on human Th2 cells. Eur J Immunol 2004; 34: 231–240
   PubMedGoogle Scholar
• Katakura T, Miyazaki M, Kobayashi M, Herndon DN, Suzuki F. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 2004; 172: 1407–1413
   PubMed Web of Science ®Google Scholar
• Matsukawa A, Hogaboam CM, Lukacs NW, et al. Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J Immunol 2000; 164: 5362–5368
   Google Scholar
• Blease K, Jakubzick C, Schuh JM, et al. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J Immunol 2001; 167: 6583–6592
   PubMed Web of Science ®Google Scholar
• Schuh JM, Blease K, Bruhl H, Mack M, Hogaboam CM. Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma. Eur J Immunol 2003; 33: 3080–3090
   PubMed Web of Science ®Google Scholar
• Blease K, Mehrad B, Standiford TJ, et al. Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol 2000; 165: 1564–1572
   PubMed Web of Science ®Google Scholar
• Schuh JM, Blease K, Hogaboam CM. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 2002; 168: 1447–1456
   PubMed Web of Science ®Google Scholar
• Schuh JM, Power CA, Proudfoot AE, et al. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4 − /− mice. Faseb J 2002; 16: 1313–1315
   PubMed Web of Science ®Google Scholar
• Blease K, Mehrad B, Lukacs NW, et al. Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. J Immunol 2001; 166: 1832–1842
   PubMed Web of Science ®Google Scholar
• Conroy DM, Jopling LA, Lloyd CM, et al. CCR4 blockade does not inhibit allergic airways inflammation. J Leukoc Biol 2003; 74: 558–563
   PubMed Web of Science ®Google Scholar
• Kawasaki S, Takizawa H, Yoneyama H, et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001; 166: 2055–2062
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Delaney T, Nguyen T, et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000; 191: 265–274
   PubMed Web of Science ®Google Scholar
• Chvatchko Y, Hoogewerf AJ, Meyer A, et al. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med 2000; 191: 1755–1764
   PubMed Web of Science ®Google Scholar
• Meier A, Kirschning CJ, Nikolaus T, et al. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003; 5: 561–570
   PubMed Web of Science ®Google Scholar
• Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320–39326
   PubMed Web of Science ®Google Scholar
• Colonna M, Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 2003; 187 Suppl 2: S397–S401
   PubMed Web of Science ®Google Scholar
• Radsak MP, Salih HR, Rammensee HG, Schild H. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 2004; 172: 4956–4963
   PubMed Web of Science ®Google Scholar
• Aoki N, Zganiacz A, Margetts P, Xing Z. Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect Immun 2004; 72: 2477–2483
   PubMed Web of Science ®Google Scholar
• Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103–1107
   PubMed Web of Science ®Google Scholar
• Nochi H, Aoki N, Oikawa K, et al. Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. Am J Pathol 2003; 162: 1191–1201
   PubMed Web of Science ®Google Scholar
• Redecke V, Hacker H, Datta SK, et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172: 2739–2743
   PubMed Web of Science ®Google Scholar